BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 315841)

  • 1. Circulating immune complexes in patients with cryptogenic fibrosing alveolitis.
    Haslam PL; Thompson B; Mohammed I; Townsend PJ; Hodson ME; Holborow EJ; Turner-Warwick M
    Clin Exp Immunol; 1979 Sep; 37(3):381-90. PubMed ID: 315841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of cryoglobulinaemia with nodules, vasculitis and fibrosing alveolitis in rheumatoid arthritis and their relationship to serum C1q binding activity and rheumatoid factor.
    Erhardt CC; Mumford P; Maini RN
    Clin Exp Immunol; 1979 Dec; 38(3):405-13. PubMed ID: 535182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies to DNA topoisomerase II in cryptogenic fibrosing alveolitis and connective tissue disease.
    Meliconi R; Bestagno M; Sturani C; Negri C; Galavotti V; Sala C; Facchini A; Ciarrocchi G; Gasbarrini G; Astaldi Ricotti GC
    Clin Exp Immunol; 1989 May; 76(2):184-9. PubMed ID: 2547538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C1q binding activity in the sera of patients with chronic lung diseases.
    Cooper KM; Moore M; Hilton AM
    Clin Exp Immunol; 1981 Jul; 45(1):18-28. PubMed ID: 6975678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of circulating immune complexes in 'lone' cryptogenic fibrosing alveolitis and those with associated connective tissue disorders.
    Martinet Y; Haslam PL; Turner-Warwick M
    Clin Allergy; 1984 Sep; 14(5):491-7. PubMed ID: 6333299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating immune complexes after renal transplantation. Correlation of increased 125I-Clq binding activity with acute rejection characterized by fibrin deposition in the kidney.
    Ooi YM; Ooi BS; Vallota EH; First MR; Pollak VE
    J Clin Invest; 1977 Sep; 60(3):611-9. PubMed ID: 330564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating immune complexes in onchocerciasis.
    Paganelli R; Ngu JL; Levinsky RJ
    Clin Exp Immunol; 1980 Mar; 39(3):570-5. PubMed ID: 7379329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating complement breakdown products in patients with rheumatoid arthritis. Correlation between plasma C3d, circulating immune complexes, and clinical activity.
    Nydegger UE; Zubler RH; Gabay R; Joliat G; Karagevrekis CH; Lambert PH; Miescher PA
    J Clin Invest; 1977 May; 59(5):862-8. PubMed ID: 853126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of immune complexes. The use of radioimmunoassays with Clq and monoclonal rheumatoid factor.
    Gabriel A; Agnello V
    J Clin Invest; 1977 May; 59(5):990-1001. PubMed ID: 323292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digital vasculitis in patients with cryptogenic fibrosing alveolitis.
    Hodson ME; Haslam PL; Spiro SG; Turner-Warwick M
    Br J Dis Chest; 1984 Apr; 78(2):140-8. PubMed ID: 6722017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating immune complexes in rheumatoid arthritis: a prospective study using five immunoassays.
    Reynolds WJ; Yoon SJ; Emin M; Chapman KR; Klein MH
    J Rheumatol; 1986 Aug; 13(4):700-6. PubMed ID: 3490573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune complexes and antibodies to BCG in sera from patients with mycobacterial infections.
    Carr RI; Chakraborty AK; Brunda MJ; Davidson PT; Damle PB; Hardtke MA; Gilbride KJ; Minden P
    Clin Exp Immunol; 1980 Mar; 39(3):562-9. PubMed ID: 6991170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of immune complexes and immunoglobulin G antibodies reactive with neutrophils in the sera of patients with Felty's syndrome.
    Starkebaum G; Arend WP; Nardella FA; Gavin SE
    J Lab Clin Med; 1980 Aug; 96(2):238-51. PubMed ID: 6772719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired antibody-dependent cell-mediated cytotoxicity in cryptogenic fibrosing alveolitis (synonym: idiopathic pulmonary fibrosis).
    Haslam PL; Allan F; Watling AF; Barrett C; Morris L; Turner-Warwick M
    Clin Exp Immunol; 1982 Jul; 49(1):59-66. PubMed ID: 7127903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating immune complexes in Lyme arthritis. Detection by the 125I-C1q binding, C1q solid phase, and Raji cell assays.
    Hardin JA; Walker LC; Steere AC; Trumble TC; Tung KS; Williams RC; Ruddy S; Malawista SE
    J Clin Invest; 1979 Mar; 63(3):468-77. PubMed ID: 429566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune complexes in early arthritis. L Detection of immune complexes before rheumatoid arthritis is definite.
    Jones VE; Jacoby RK; Wallington T; Holt P
    Clin Exp Immunol; 1981 Jun; 44(3):512-21. PubMed ID: 6976861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating immune complexes and rheumatoid arthritis.
    Faaber P; Rijke Schilder TP; Capel PJ; Koene RA
    J Rheumatol; 1985 Oct; 12(5):849-53. PubMed ID: 3878875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating immune complexes in Indian childhood cirrhosis.
    Kalra V; Harkiss GD; Lachmann PJ; Ghai OP
    Clin Exp Immunol; 1982 Oct; 50(1):1-6. PubMed ID: 6924609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of antirheumatic drugs on circulating immune complexes in rheumatoid arthritis.
    Forster PJ; McConkey B
    Q J Med; 1986 Jan; 58(225):29-42. PubMed ID: 2871585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of immune complexes in rheumatoid disease.
    Fleming A; Charlesworth J; Liew M; Portek I; Bertouch J; Quin J
    Aust N Z J Med; 1981 Jun; 11(3):231-4. PubMed ID: 6945832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.